# A Research Study on How Well Concizumab Works for You if You Have Haemophilia A or B With or Without Inhibitors

> **NCT05135559** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Novo Nordisk A/S** · enrollment: 153 (estimated)

## Conditions studied

- Haemophilia A and B With and Without Inhibitors

## Interventions

- **DRUG:** Concizumab

## Key facts

- **NCT ID:** NCT05135559
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-03-24
- **Primary completion:** 2026-04-21
- **Final completion:** 2029-11-02
- **Target enrollment:** 153 (ESTIMATED)
- **Last updated:** 2025-12-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05135559

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05135559, "A Research Study on How Well Concizumab Works for You if You Have Haemophilia A or B With or Without Inhibitors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05135559. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*